Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Retention Rates of Genetic Therapies Based on AAV Serotypes 2 and 8 Using Different Drug-Delivery Materials.

Journal article

Reichel FF. et al, (2024), International journal of molecular sciences, 25

Trendbericht Anorganik 2024: Hauptgruppen- und Molekülchemie

Journal article

Fischer M. and Heift D., (2024), Nachrichten aus der Chemie, 72, 46 - 57

En Route to a Molecular Terminal Tin Oxide

Journal article

Kreßner L. et al, (2024), Inorganic Chemistry

Phosphaarsenes – Combining Phospha- and Arsa-Wittig-Reagents

Journal article

Beer H. et al, (2024), ChemPlusChem

Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations

Journal article

von Krusenstiern L. et al, (2023), JAMA Ophthalmology, 141, 275 - 275

Trendbericht Anorganische Chemie 2023: Hauptgruppen

Journal article

Heift D. and Fischer M., (2023), Nachrichten aus der Chemie, 71, 46 - 57

Gene therapy for inherited retinal disease: long-term durability of effect.

Journal article

Leroy BP. et al, (2022), Ophthalmic Res

Development of a functional assay for the assessment of two common CRB1 mutations

Conference paper

Bellingrath J-S. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63

Neural plasticity of the human visual system reflects treatment effect in gene therapy for Achromatopsia

Conference paper

Seitz IP. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63

PERCEIVE study report: Real-world safety and effectiveness of voretigene neparvovec

Conference paper

Fischer MD. et al, (2022), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 63

Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec.

Journal article

Reichel FF. et al, (2022), Br J Ophthalmol

Load More